Updates to the Clinician’s Guide to the Prevention and Treatment of Osteoporosis

 

Update# 2015.11.11

In 2015, the National Osteoporosis Foundation (NOF) endorsed the Clinical Diagnosis of Osteoporosis[1] a position paper from the National Bone Health Alliance (NBHA).  At its most recent meeting (November 11, 2015), the NOF Board of Trustees recommended that the Clinician’s Guide to the Prevention and Treatment of Osteoporosis[2] (Clinician’s Guide) be updated to reflect the expanded criteria which may be used to establish a clinical diagnosis of osteoporosis as described in the position paper.

Based upon the NBHA position paper, a clinical diagnosis of osteoporosis may be made in a postmenopausal woman or in a man over age 50 who is at an elevated risk for fracture due to any of the following:

  • T-score ≤-2.5 at the spine or hip as determined by DXA,  or
  • Hip fracture with or without BMD testing, or
  • Vertebral, proximal humerus, pelvis, or in some case distal forearm fracture in setting of low bone mass (osteopenia) by DXA, or
  • FRAX score with 10 year risk for hip fracture ≥3% or for major osteoporotic fracture ≥20% in a patient with osteopenia.

To read the full publication, please follow this link: http://link.springer.com/article/10.1007/s00198-014-2655-z  



[1] Siris ES, Adler R, Bilezikian J, et al. The Clinical Diagnosis of Osteoporosis: A Position Statement from the National Bone Health Alliance Working Group. Osteoporos Int, (2014) 25: 1439-1443.

[2] Cosman F, Jan de Buer S, LeBoff MS, et al. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int, (2014) 25: 2359-2381.